Fc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their Immunogenicity.

Lagassé, H A Daniel

Fc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their Immunogenicity. [electronic resource] - The AAPS journal 05 2019 - 62 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Intramural

1550-7416

10.1208/s12248-019-0336-8 doi


Animals
Antibodies, Monoclonal--immunology
Cell Line, Tumor
Complement C1q--immunology
Drug Hypersensitivity--immunology
Histocompatibility Antigens Class I--immunology
Humans
Immunoglobulin Fc Fragments--immunology
Mice
Protein Binding
Receptors, Fc--immunology
Receptors, IgG--metabolism
Signal Transduction